viewMarrone Bio Innovations

Marrone Bio inks South Africa distribution deal for REGALIA MAXX fungicide

The product will be used by grape growers in the country to prevent disease in their crops while also reducing chemical residues

Grape wineland countryside landscape background of hills with mountain backdrop in Cape Town South Africa
Marrone's products are made from naturally occurring substances such as microbes, bacteria, plant extracts, fatty acids or pheromones

Marrone Bio Innovations Inc (NASDAQ:MBII) shares jumped Friday after the company announced an exclusive commercial agreement with multinational agribusiness UPL to distribute its REGALIA MAXX Fungicide in South Africa.

South Africa is a major producer of wine and table grapes, with more than 120,000 hectares in production. Marrone’s REGALIA MAXX stimulates plants’ ability to fight diseases and has been used in North America to manage botrytis and other grape diseases.

“We know growers around the world are looking for more environmentally-friendly and effective products,” Marrone Chief Commercial Officer Kevin Hammill said in a statement. “Developing a strategic partnership with UPL, an organization that shares a common vision for the value biologicals provide growers, will allow MBI to capitalize on our product portfolio and expand our global footprint.”

READ: Marrone Bio Innovations receives first approval for REGALIA MAXX for cannabis and hemp in Canada

South Africa is one of the largest crop protection markets in Africa, valued at roughly $300 million. Danie Marais, UPL’s head of marketing for Africa, the Middle East, Australia and New Zealand, believes Marrone’s product can make a difference for farmers.

“UPL is excited to partner with MBI and provide South African farmers with MBI’s leading biological solution, REGALIA MAXX,” Marais said. “Access to this product will enable our farmers to add value to their export crops by lowering chemical residues and providing consumers with quality produce. 

“The introduction of REGALIA MAXX to UPL’s bio-solutions product range is an excellent starting point, in what we anticipate to be a long, mutually beneficial and rewarding relationship between UPL and MBI.”

Marrone Bio has also submitted registration for its bioinsecticide GRANDEVO in the country.

The Davis, California-based company’s products are made from naturally occurring substances such as microbes, bacteria, plant extracts, fatty acids or pheromones.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Marrone Bio Innovations

Price: 1.16 USD

Market: NASDAQ
Market Cap: $176.87 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...


Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

on 09/25/2020

2 min read